The death of a cell is an inevitable part of its biology. During homeostasis, most cells die through apoptosis. If homeostasis is disturbed, cell death can switch to proinflammatory forms of death, such as necroptosis, pyroptosis, or NETosis. We demonstrate that the formation of neutrophil extracellular traps (NETs), a special form of neutrophil cell death that releases chromatin structures to the extracellular space, is dependent on gasdermin D (GSDMD). GSDMD is a pore-forming protein and an executor of pyroptosis. We screened a chemical library and found a small molecule based on the pyrazolo-oxazepine scaffold that efficiently blocks NET formation and GSDMD-mediated pyroptotic cell death in human cells. During NETosis, GSDMD is proteolytically activated by neutrophil proteases and, in turn, affects protease activation and nuclear expansion in a feed-forward loop. In addition to the central role of GSDMD in pyroptosis, we propose that GSDMD also plays an essential function in NETosis.
INTRODUCTION
Disturbance of host homeostasis can lead to proinflammatory forms of cell death that result in cell lysis (1) . This lysis is beneficial for the host because it amplifies inflammatory signals, but it can have patho logical consequences. Inflammasomes are protein complexes that as semble upon sensing a broad variety of danger signals and activate inflammatory caspases. These cysteine proteases activate the pro inflammatory cytokines interleukin1 (IL1) and IL18 and are re quired for pyroptosis (2, 3) . Caspase1 processes IL1/IL18 during canonical inflammasome activation, whereas caspase4 and caspase5 in humans (or their ortholog caspase11 in mice) are activated in noncanonical inflammasomes in response to intracellular lipopoly saccharide (LPS) (4, 5) . The pyroptotic substrate is the poreforming protein gasdermin D (GSDMD) (6, 7) . The Cterminal domain of GSDMD inhibits the poreforming capacity of the N terminus. Caspasemediated cleavage liberates the Nterminal domain that multimerizes and lyses the cell by membrane rupture (8) (9) (10) (11) . Caspase11-and GSDMDdeficient mice are protected from septic shock induced by LPS (4, 7) , demonstrating the importance of py roptosis in driving LPSinduced inflammation in vivo.
Distinct from pyroptosis that preferentially occurs in macro phages and monocytes, NETosis is a neutrophil cell death pathway that leads to the release of chromatin decorated with specific pro teins (12) . These chromatin protein structures, called neutrophil ex tracellular traps (NETs), capture microorganisms, activate myeloid cells, and promote coagulation (13) . During NETosis, in contrast to other forms of cell death, the nucleus disintegrates before the cyto plasmic membrane is compromised and chromatin is released to the extracellular space. NETs are a doubleedged sword; they are bene ficial in infections but pathogenic by exposing autoantigens and promoting thrombosis (14) . Hence, NETs are a promising drug tar get for various pathologies (13) .
Different NETinducing stimuli engage diverse pathways, com plicating the analysis of NETosis (15) . Activation with microbes or mitogens (16) , like phorbol 12myristate 13acetate (PMA), gener ates reactive oxygen species (ROS) by the NADPH (reduced form of nicotinamide adenine dinucleotide phosphate) oxidase complex (NOX2), which activates mitogenactivated protein (MAP) kinase signaling. ROS signaling releases a macromolecular complex called azurosome from granules, which translocates neutrophil elastase (NE) to the nucleus (17, 18) . NE processes histones, which coincides with chromatin expansion in the whole cell before the plasma membrane rupture and NET release (19) . We do not understand how neutro phils lyse to liberate NETs. Here, through a large screen of small mole cules, we have identified a compound that blocks NET formation. This compound blocks cell lysis by binding to GSDMD and inhibits both pyroptosis and NETosis. In neutrophils, GSDMD is cleaved by serine proteases, like NE, and allows the release of granular proteins that are required for NETosis progression in a feedforward loop.
RESULTS

Identification of molecules that inhibit NET formation
Because neutrophils are shortlived, terminally differentiated cells that preclude genetic manipulation, we screened a library of 182,710 small molecules to identify PMAinduced NETosis inhibitors in neutrophils isolated from healthy volunteers. We scored cells for NET formation by automated microscopy ( fig. S1A) (17) . We iden tified a compound class of NET formation inhibitors based on the pyrazolooxazepine scaffold, which potently inhibited PMAinduced NETosis (Fig. 1, A and B) . A member of this class, LDC7559, was not toxic to peripheral blood mononuclear cells (PBMCs). It efficiently inhibited PMAinduced NET formation with an IC 50 (median in hibitory concentration) of 5.61 M and the biologically relevant cho lesterol crystalinduced NET formation (20) with an IC 50 of 0.304 M (Fig. 1B and fig. S1 , B to D). This compound did not block NADPH oxi dase, NE, or myeloperoxidase (MPO) activity (Fig. 1B and fig. S1 , E to G), suggesting that it acted downstream of NOX2 and the azurosome. (G) Results of MS, showing enrichment of GSDMD peptides upon pulldown with LDC2618 and competition by LDC7559 in two independent experiments. Peptides for NOX2 and MPO were identified but not enriched upon pulldown and not competed by LDC7559. (C to E) Mean ± SEM of three independent experiments. *P < 0.05, oneway analysis of variance (ANOVA) with Dunnett's multiple comparisons test. DMSO, dimethyl sulfoxide; ns, not significant.
LC-MS/MS analysis and target identification
LDC7559 transiently decreased ROS production after the initial peak in human primary neutrophils (Fig. 1C ), although this reduction was too small to affect NETosis, as shown later in this study (Fig. 6B) . The compound did not block phagocytic activity of human primary neutrophils, which is in line with our findings that it specifically in hibited NET formation (Fig. 1D) . We verified our results from the screen by treating neutrophils with PMA and measuring NET for mation over time and found that even 1 M LDC7559 potently de layed NET formation (Fig. 1E and fig. S2A ).
LDC7559 binds to GSDMD and inhibits inflammasome activation
We identified the target of LDC7559 by affinity chromatography. We used LDC2618 ( fig. S2B ), a derivative of the initial hit as bait, to pull down proteins bound to this compound class from cell lysates and verified specific binding by competition with the initial hit com pound LDC7559 (Fig. 1F) . We analyzed the pulldowns by mass spec trometry (MS) and identified several peptides corresponding to GSDMD, which was the most enriched protein (Fig. 1G and fig. S2 , C and D). Furthermore, in the affinity chromatography, we did not enrich peptides corresponding to NOX2 or MPO (Fig. 1G) , two abun dant proteins in neutrophils. These results are consistent with the fact that LDC7559 did not inhibit the activity of these two enzymes (Fig. 1B) and suggest that the compound specifically binds GSDMD.
To confirm that LDC7559 inhibits GSDMDdependent processes, we tested the effects of this compound on pyroptosis in human pri mary monocytes, the monocytic cell line THP1 and murine immor talized bone marrow-derived macrophages (BMDMs). LDC7559 blocked IL1 release in human primary monocytes incubated with silica crystals to activate the NLRP3 inflammasome ( Fig. 2A ) and upon poly(deoxyadenosinedeoxythymidine) [poly(dAdT)] transfection to stimulate the Aim2 inflammasome (Fig. 2B) . Previous studies demonstrated that lysis by canonical inflammasomes depends only partially on GSDMD because deficiency in this gene delays, rather than abolishes, IL1 release (7). Therefore, we also activated the noncanonical inflammasome by LPS transfection in THP1 cells and showed that the LDC7559 treatment inhibited IL1 release (Fig. 2C ).
In immortalized murine BMDMs, LDC7559 also reduced IL1 release upon LPS delivery to the cytoplasm, demonstrating that LDC7559 is active on human and murine cells (Fig. 2D ).
Human embryonic kidney (HEK) 293T cells do not express GSDMD; however, transfection of the N terminus, but not the full length or C terminus of this protein, is toxic (6) . LDC7559 blocked the toxicity of the N terminus of both human and murine GSDMD (Fig. 2 , E and F), indicating that LDC7559 affects GSDMD activity directly. As expected, because the toxicity of the Nterminal GSDMD is independent of caspases, inhibitors of these proteases did not in hibit cell death in this assay (Fig. 2E) . Together, these data show that LDC7559 blocks the activity of the GSDMD N terminus.
GSDMD is cleaved during NET formation and localizes to the plasma membrane
Upon neutrophil activation with PMA, fulllength GSDMD levels were reduced ( fig. S3A ). As controls, we used neutrophils isolated from a patient with Xlinked chronic granulomatous disease (CGD). CGD patients carry mutations in NOX2 and do not form NETs upon PMA stimulation (21) . In PMAtreated neutrophils isolated from this CGD patient, levels of fulllength GSDMD remained intact ( fig. S3A ). In some cases, probably dependent on donors and timing, we observed the appearance of a 25 to 30kDa fragment, corresponding Fig. 3 . GSDMD localizes to the plasma membrane and is processed during NET formation. (A) Western blot of human primary neutrophils isolated from a control donor (ctr.) or from a patient with X-linked CGD after stimulation with PMA for 2.5 hours. GSDMD was detected with an antibody directed against full-length GSDMD. In this control, donor loss of full-length GSDMD corresponded with the occurrence of a processed N terminus, which is marked by an arrow. (B) Microscopy images of human primary neutrophils activated for the indicated time points with PMA and stained with antibodies against GSDMD and NE as well as with the DNA dye DAPI; membranes were stained with DiI. GSDMD is detected in remnants of cells that had made a NET (white arrows). Images were acquired at the coverslip level; therefore, spread NETs are not seen. Scale bars, 10 m. (C) High-resolution TIRF microscopy of human primary neutrophils undergoing NET formation. Cells were fixed at the indicated time points after PMA stimulation in the presence or absence of 5 M LDC7559. Plasma membranes were stained with DiD. Scale bars, 10 m. (D) Quantification of TIRF microscopy. Background signal was determined outside the cells, and GSDMD signal (at least 2× background fluorescence intensity) in the TIRF zone was analyzed. Mean ± SEM of three independent experiments is depicted. ***P < 0.001, unpaired two-tailed t test. . FL, full-length GSDMD. (C to E and G) GSDMD was detected by Western blotting using an antibody directed against full-length GSDMD. Arrows indicate active fragment. *P < 0.05, **P < 0.01, ***P < 0.001, one-way ANOVA with Dunnett's multiple comparisons test.
to the lytic N terminus of the protein, upon loss of fulllength GSDMD (Fig. 3A) . Consistent with the data showing that NOX2 is upstream of GSDMD activation, GSDMD was not cleaved upon PMA stimu lation in CGD patient neutrophils (Fig. 3A) . We stained primary neutrophils for GSDMD with an antibody that recognizes both full length and processed GSDMD and found that it localized primarily to the cytoplasm in nonstimulated cells (Fig. 3B) . We also found GSDMD on NETs ( fig. S3B ) and a strong signal in remnants of NETforming neutrophils (Fig. 3B and fig. S3C ). This is consistent with the local ization of the GSDMD N terminus to the plasma membrane of cells undergoing pyroptosis (8) (9) (10) (11) . Furthermore, using highresolution total internal reflection fluorescence (TIRF) microscopy, we found that as NETosis progressed, GSDMD accumulated at the TIRF zone, indicating that it localized to the plasma membrane (Fig. 3, C and D,  and fig. S3, D to F) . We quantified the percentage of GSDMD de tected by TIRF in the presence or absence of LDC7559 and found that GSDMD membrane localization was markedly reduced by the compound, suggesting that it inhibits GSDMD cleavage or mem brane integration in neutrophils (Fig. 3, C and D, and fig. S3 , D to F). We did not observe NE in the TIRF zone of either naïve or PMA treated neutrophils ( fig. S4 ), indicating that the translocation of GSDMD to the membrane is specific. Together, these experiments demonstrate that GSDMD is cleaved during NET formation and then localizes to the plasma membrane of neutrophils.
Neutrophil serine proteases process GSDMD
NETosis is independent of caspases, because neither the pancaspase inhibitor ZVADFMK nor the caspase1/4-specific inhibitor VX765, which efficiently blocks pyroptosis (22) , was able to reduce NET for mation (Fig. 4, A and B, and fig. S5 , A to C) (23) . To identify the protease that cleaves GSDMD during NETosis, we incubated lysates of HEK293T cells expressing fulllength GSDMD with neutrophil lysates and found processing of the fulllength protein into a frag ment between 25 and 30 kDa resembling the active GSDMD N ter minus (Fig. 4C) . Neutrophils express three main proteases-NE, proteinase 3 (PR3), and cathepsin G (CG)-all of which have pro miscuous target recognition. However, inhibition of NE alone was suf ficient to substantially reduce GSDMD cleavage (Fig. 4C) . LDC7559 did not inhibit this processing (Fig. 4C ), in line with the finding that the compound did not inhibit NE activity (Fig. 1C) . Complementary to this approach, we incubated GSDMD from HEK293T lysates with purified and recombinant proteases. Whereas caspase4 and NE readily processed GSDMD into a fragment of similar size, CG and PR3 were far less efficient at cleaving GSDMD (Fig. 4D) . Again, LDC7559 did not interfere with GSDMD processing, confirming that it is not a protease inhibitor and showing that it does not render GSDMD cleavageresistant ( fig. S5D) .
Because NE and caspase4 generate an N terminus of similar size, we speculated that the cleavage sites would be in the same region. Caspase4 cleaves GSDMD at amino acid 275, and the first 243 amino acids of GSDMD are required to induce pyroptosis (6) . Using the ExPASy PeptideCutter tool (24), we identified five potential NE cleavage sites in the region between amino acids 243 and 282 that could result in a functional fragment (Fig. 4E) . Constructs with single point mutations in these sites were still cleaved by purified NE (Fig. 4E) , which is consistent with several redundant cleavage sites. Expression of the GSDMD N terminus corresponding to all but the shortest of the five putative NEinduced fragments induced lysis in HEK293T cells. The fragment ranging from amino acid 1 to 255 was the most effective (Fig. 4F) . Lysis induced by these N termini could be inhibited by LDC7559 ( fig. S5E ). To identify NE cleavage regions, we further gen erated deletion mutants lacking four amino acid stretches around the caspase cleavage site and expressed those constructs in HEK293T cells (Fig. 4G) . As expected, deletion of D275 abrogated the sensitivity of GSDMD to caspase4. We also observed that deletion of amino acids 279 to 282 made the protein insensitive to caspase4, probably due to effects on protein folding. These deletions also made GSDMD less sensitive to NE (Fig. 4G) , suggesting that NE cleaves GSDMD at var ious positions between amino acids 275 and 282. We also generated a mutant GSDMD lacking amino acids 255 to 258 and found that this mutant was moderately more resistant to NE cleavage, indicating that position 255 could contribute to GSDMD processing ( fig. S5F ). We found that deletion of amino acids 267 to 270 resulted in a protein that could still be processed by caspase4 but was more resistant to NE cleavage (Fig. 4G) . This is consistent with a recent report demonstrating that NE cleaves GSDMD at position C268 (25) . NE therefore cleaves GSDMD at several sites, resulting in lysisinducing fragments. Mean ± SEM of three independent experiments. *P < 0.05, **P < 0.01, ***P < 0.001, one-way ANOVA with Dunnett's multiple comparisons test.
GSDMD is required for NETosis
To genetically confirm the requirement of GSDMD in NETosis, we isolated neutrophils of GSDMD mutant mice (7) and activated them with PMA. NET formation in GSDMD mutant neutrophils was signifi cantly reduced (Fig. 5, A and B) , demonstrating a requirement of GSDMD for NETosis.
We next asked mechanistically where GSDMD acts in the path way of NET formation. LDC7559 did not affect neutrophil lysis upon addition of the detergent digitonin, indicating that the effects of this compound are not simply stabilizing the cell membrane ( fig. S6A) . Furthermore, when we tried to wash out LDC7559 at different time points after PMA treatment, we did not detect significant changes in cell lysis, arguing that LDC7559 acts intracellularly ( fig. S6B ). LDC7559 blocked a ROSdependent NET formation pathway (Figs. 1,  C and F, and 6A and fig. S6C ) but did not inhibit NET formation in response to nigericin, which acts independent of ROS production ( Fig. 6A and fig. S6, D and E) . Furthermore, PMA or nigericin treat ment did not induce IL1 release from neutrophils, again demon strating that the cell death we saw occurred independent of inflam masome activation ( fig. S6, F and G) . Because LDC7559 transiently reduced ROS production upon PMA treatment, we tested whether this effect was sufficient to block NETosis. To determine the mini mal amount of ROS required, we titrated the ROS scavenger pyro catechol to reach different levels of ROS production (Fig. 6B) . The concentration of pyrocatechol that reduced ROS production simi larly to LDC7559 treatment did not inhibit NETosis (Fig. 6C) . We also showed that adding LDC7559 blocked NETosis even if added up to 30 min after PMA induction, which is a time point when neu trophils had already mounted an oxidative burst (Fig. 6D) . Together, these experiments suggest that LDC7559 and GSDMD act down stream of the oxidative burst.
During NET formation, ROS production facilitates NE release from granules through dissociation from a multiprotein aggregate. NE then degrades actin and enters the nucleus where it processes D) and stained with the cell-permeable DNA dye DRAQ5 and the cell-impermeable DNA dye SYTOX Green. Images were acquired every 2 min for 6 hours. Single cells were selected semiautomatically; nuclear expansion and NET formation were quantified using an automated workflow in ImageJ and R. Bottom panels depict P values determined by unpaired two-tailed t tests at each time point, and red areas refer to P < 0.05. Mean ± SEM is depicted; n refers to the number of independent experiments. histones (18, 19) . LDC7559 treatment strongly reduced actin degra dation, and both MPO ( fig. S6H ) and NE (Fig. 6E ) remained in granules, indicating that GSDMD has a role upstream of NE mobi lization from granules. Together with the observation that NE activity is required for GSDMD processing, these results suggest a feed forward loop where GSDMD and NE use each other for their acti vation. Both the NE inhibitor and LDC7559 reduced processing of GSDMD during PMAinduced NETosis (Fig. 6F) , and LDC7559 re duced processing of histone H3, which is an indicator of NE activity during NETosis (Fig. 6G) .
GSDMD affects nuclear expansion during NET formation
Last, we addressed how the NEGSDMD axis affects the dynamics of NET formation using a livecell imaging approach with the cell permeable DNA dye DRAQ5 and the cellimpermeable DNA dye SYTOX Green. This dual staining allowed us to quantify changes in nuclear area, permeability, and lysis in single cells over time (movie S1 and fig. S7, A to D) . LDC7559 strongly reduced NET release upon PMA treatment but not upon NET induction with nigericin, con firming our previous results (Fig. 7, A and B, and movies S2 to S5). NET release depends on two processes: nuclear expansion and cel lular lysis. NET stimuli that induce no or only marginal GSDMD cleavage, such as nigericin ( fig. S7E ), showed similar kinetics of nuclear expansion in the presence or absence of LDC7559. However, the nuclear expansion of PMAtreated neutrophils was significantly reduced upon LDC7559 treatment (Fig. 7, C and D) . To a lower extent, we also saw an impact of LDC7559 on NET formation and nuclear expansion in response to the calcium ionophore A23187 (fig. S7, F and G) .
LDC7559 did not only reduce the number of cells that expanded their nucleus but also slowed down the kinetics of nuclear expan sion in the remaining ones (Fig. 7E) . This is consistent with the in hibition of an NEGSDMD feedback loop upon PMA induction of NETosis ( fig. S8 ). However, once these cells reached a state with an expanded nucleus, the time interval to cell lysis was similar in the absence or presence of LDC7559 (Fig. 7F) . This finding suggests that, once the NEGSDMD axis resulted in NE activity that allowed nuclear expansion, the levels of cleaved GSDMD are sufficiently high for cellular lysis.
DISCUSSION
Pyroptosis and NETosis are often activated in similar disease pro cesses where immune defense, against either sterile or microbial in sults, is required, and both of these forms of cell death are involved in similar pathologies. However, mechanistically, there are differ ences between pyroptosis and NETosis: Pyroptosis relies on pro inflammatory caspase activity, and it removes the niche for intracellular pathogens and activates IL1. NETosis, on the other hand, requires neutrophil serine proteases, and NETs capture extracellular micro organisms and stimulate other leukocytes. Here, we report that there is a common executioner protein through which both cell death path ways converge: GSDMD. Our data show that processing of GSDMD into a lethal fragment can be adapted by different pathways and proteases. This is in line with other reports showing that apoptotic caspases can process the gasdermin family member DFNA5 into a lytic form to drive secondary necrosis (26, 27) .
Also published in this issue, Chen et al. (28) report that, upon activation of noncanonical inflammasomes, neutrophils also release NETs dependent on GSDMD. Thus, the two studies together show that, in neutrophils, different stimuli activate diverse proteases that cleave GSDMD to execute NETosis. Intracellular LPS promotes in flammasome assembly and caspase cleavage of GSDMD, whereas classical NETosis requires ROS that activate serine proteases that also cleave GSDMD. These data suggest that GSDMD is a hub of proinflammatory cell death.
On the basis of the data presented here, we propose that GSDMD has two functions ( fig. S8) . First, NE and GSDMD engage in a feed forward loop in which the protease activates GSDMD. Activated GSDMD, in turn, forms pores in the granule membrane, thus enhanc ing NE release into the cytoplasm and allowing further GSDMD cleavage in a reiterative process. This enables the translocation of NE to the nucleus, where it processes histones and allows nuclear ex pansion (18) . Second, upon completion of NETosis, cleaved GSDMD forms pores in the plasma membrane, allowing NET release. Classical NETosis requires ROS production and the activation of MPO to release NE into the cytoplasm (18) . Our data support the model that GSDMD activity is downstream of initial NE release, but further inves tigation should address the involvement of MPO, and other putative components required for NETosis, such as PAD4, on GSDMD acti vation. This also suggests that degranulation of neutrophils might constitute an event that inhibits NETosis, which would be consist ent with the finding that neutrophils treated with formylated pep tides such as NformylMetLeuPhe (fMLP) (a strong inducer of degranulation) produce ROS but do not form NETs (16) , and it will be interesting to analyze the impact of degranulation on GSDMD activation in neutrophils.
Our data are consistent with a recent report by Kambara et al. (25) , describing that GSDMDdeficient neutrophils are longerlived than wildtype (WT) cells, which is an important aspect of neutro phil biology, because these cells are notoriously shortlived. Upon neutrophil aging, NE is released from damaged granules and pro cesses GSDMD into an active fragment. Kambara et al. also showed that GSDMDdeficient mice are more resistant to an Escherichia coli challenge, probably because this microbe is susceptible to phagocyto sis, and the extended life of neutrophils is protective. Thus, GSDMD activation might be detrimental in infections where neutrophil phago cytosis is effective and beneficial when NETs are required, for example, in fungal infections. Furthermore, the N terminus of GSDMD has been shown to have antimicrobial properties (8) . Because we detected GSDMD on NETs, it is possible that this protein contributes to pathogen clearance not only by allowing NET release but also by directly killing extracellular microbes.
By carrying out a chemical screen to identify modulators of NETosis, we unexpectedly uncovered a compound that binds GSDMD and modulates its actions. This compound, or its deriva tives, might represent a starting point to target GSDMD function in a plethora of diseases where both inflammasome activation and NET formation are pathological including cancer, autoinflammatory, auto immune, and vascular diseases.
MATERIALS AND METHODS
Antibodies, staining reagents, and inhibitors GSDMD antibody (G7422, Sigma), NE antibody (481001, Millipore), MPO antibody (A0398, Dako), glyceraldehyde3phosphate dehy drogenase (GAPDH) antibody (14C10, Cell Signaling Technology), histone H3 antibody (ab1791, Abcam), chromatin antibody (PL2.3) (29) , SYTOX Green nucleic acid stain/SYTO Green nucleic acid stain/ SYTOX Orange nucleic acid stain (Thermo Fisher Scientific), DRAQ5 (Biostatus), Hoechst (Sigma), 4′,6diamidino2phenylindole (DAPI; Sigma), DiI/ DiD (Invitrogen), ZVADFMK (ALX260020, Enzo), ZYVADCHO (ALX260027, Enzo), ZLEVDCHO (ALX260065, Enzo), ZWEHDCHO (ALX260055, Enzo), NE inhibitor (BAY 858501) (30) , pyrocatechol (C9510, Sigma), Luminol (11050, AAT Bioquest), horseradish peroxidase (31941, Serva), and PMA (P8139, Sigma) were used.
GSDMD constructs
GSDMDGFP (green fluorescent protein) was purchased from Origene (catalog no. RG203399). GSDMD full length, GSDMD C terminus (276484), and GSDMD N terminus (1275) were cloned into vector PS100085 obtained from Origene (catalog no. PS100085). GSDMDA244S, GSDMDA255S, GSDMDV277E, GSDMD A279S, and GSDMDA282S point mutations were gener ated in GSDMD GFP vector obtained from Origene (catalog no. RG203399). GSDMDdel255258, GSDMDdel259262, GSDMD del267270, GSDMDdel271274, GSDMDdel275278, and GSDMD del279282 mutations were generated in PS100085 obtained from Origene (catalog no. PS100085).
Donor consent
Human primary neutrophils were isolated from blood samples obtained from volunteers according to the Declaration of Helsinki. All participants provided written informed consent. All samples were collected with approval from the local ethics committee.
Neutrophil isolation
Cells were purified by a first centrifugation of whole blood over Histopaque1119 (Sigma) and subsequently over a discontinuous Percoll gradient (20) . All experiments, except live imaging, were done in RPMI 1640 (without phenol red; Gibco) supplemented with 10 mM Hepes and 0.02% human serum albumin. Live imaging was done in Agilent Seahorse XF RPMI Medium (Agilent) supplemented with 10 mM glucose, 2 mM glutamine, 20 mM Hepes, and 0.02% human serum albumin at pH 7.4.
Neutrophil stimulation
Purified neutrophils were seeded at a density of 10 5 cells in 96well plates for measurements of ROS or measurements of NET forma tion by SYTOX Green. For immunofluorescence stainings and live imaging, neutrophils were seeded in Slide 8 Well ibiTreat dishes (ibidi; see respective sections). Cells were treated with inhibitors 45 min before induction of NET formation. All PMA (Sigma) stimu lations were done at 100 nM (except for highthroughput screening where PMA was added at 40 nM), and all nigericin (N7143, Sigma) stimulations were done at 15 M. All A23187 (Santa Cruz Biotech nology Inc.) stimulations were done at 5 M. Cholesterol crystals (C3045, Sigma) were added at 1 mg/ml.
Preparation of neutrophil lysates to visualize GSDMD processing by Western blotting
Neutrophils were seeded at 3 × 10 6 per well in sixwell plates. Cells were treated with 100 nM PMA or 15 M nigericin for the indicated time points and harvested by scraping adherent cells and remnants of dead cells off the plate in 8 M urea containing protease inhibitor cocktail (Sigma) and NE inhibitor. Lysates were mixed with an equal volume of 2× SDS loading buffer containing 200 mM dithiothreitol (DTT).
Mice
Mouse breeding and isolation of peritoneal neutrophils were approved by the Berlin state authority Landesamt für Gesundheit und Soziales. Animals were bred at the Max Planck Institute for Infection Biology. Mice were housed in specific pathogen-free conditions, maintained on a 12hour light/12hour dark cycle, and fed ad libitum. GSDMD mutant mice (7) were provided by Genentech.
Isolation and stimulation of murine peritoneal neutrophils
Murine neutrophils were isolated from peritoneal cavities of WT and GSDMD mutant animals after injection of casein (Sigma) intraperi toneally by centrifugation over Percoll (31) . Cells were seeded at 10 5 in 24well plates in RPMI (Gibco) containing penicillin/streptomycin (Gibco) and glutamine (Gibco), 1% murine DNase −/− serum, and murine granulocyte colonystimulating factor (100 ng/ml; PeproTech). Fortyfive minutes after seeding, cells were stimulated with 100 nM PMA for 6 hours. NETs were quantified with microscopic images after staining unfixed cells with the cellpermeable DNA dye SYTO Green and the cellimpermeable DNA dye SYTOX Orange.
For immunofluorescence staining, neutrophils were seeded at 10 5 per well in Slide 8 Well glassbottom dishes (ibidi) and treated with 100 nM PMA for 6 hours. Cells were fixed with 2% paraformaldehyde (PFA) for 30 min at room temperature. After washing with phosphatebuffered saline (PBS), cells were per meabilized with 0.1% Triton X100 at 4°C for 5 min, washed again with PBS, and blocked with 3% bovine serum albumin (BSA). Primary antibodies were added to samples overnight at 4°C. After washing with PBS, secondary antibodies were added in 3% BSA for 30 min, and after washing with PBS, images were acquired on a Leica SP8 confocal microscope. DNA was counterstained with DAPI (1 g/ml).
Transfection of GSDMD constructs in HEK293T cells
HEK293T cells were seeded the day before transfection at a density of 5 × 10 5 cells/ml. Transfection was done in OptiMEM (Gibco) using 2 g of DNA and 7 l of Lipofectamine 2000 (Thermo Fisher Scientific) for a sixwell plate or respective scaling for other surface areas. LDC7559 or caspase inhibitors were added 2 hours after trans fection, and lactate dehydrogenase (LDH) release of cells was mea sured 16 hours after transfection.
Incubation of HEK293T lysates with recombinant proteases
HEK293T cell lysate was harvested 16 hours after transfection by changing the medium of a six well to 200 l of OptiMEM containing 0.05% (v/v) Triton X100 and scraping cells off the bottom of the well. After 10 min of centrifugation at full speed and 4°C in a tabletop centrifuge, supernatants were used for cleav age assays. Fifty microliters of lysate were incubated with 10 mU of purified human NE (324681, Calbiochem), 2 U of recombinant caspase4 (ab51994, Abcam), 4 g of purified CG (RP77525, Thermo Fisher Scientific), or 6.25 g of recombinant PR3 (C628, Novoprotein) for the indicated time points at 25°C on a shaking incubator. Reactions were stopped by directly adding 50 l of 2× SDS loading buffer (at 98°C) containing 200 mM DTT and by im mediately boiling samples before loading on SDS-polyacrylamide gel electrophoresis gels.
Immunofluorescence staining
Neutrophils were resuspended at 6.6 × 10 5 cells/ml in RPMI con taining 0.02% human serum albumin and 10 mM Hepes, and 300 l of cell suspension was dropped into Slide 8 Well glassbottom dishes (ibidi). After 30 min, PMA was added. A pH shift fix was performed [3% PFA-KPipes (80 mM) (pH 6.8) for 5 min followed by 3% PFAborax (100 mM) for 10 min]. CellTracker DiI or DiD (Life Technologies) was used at 1 M for 2 min to stain the mem brane, and cells were subsequently permeabilized using 0.1% Triton X100 at 4°C for 2 min. Cells were then blocked (5% goat serum, 1% fish gelatin, 2% BSA) for 1 hour followed by incubation with pri mary antibody in 0.1% BSA at 4°C overnight, washed once, and then incubated with Alexa Fluor-coupled secondary antibodies (Life Technologies) at room temperature for 20 min. After three PBS washes and one incubation in distilled water for 20 min, cells were imaged in PBS using either Leica SP8 confocal microscopy or total internal reflection microscopy. DNA was counterstained with Hoechst (5 g/ml) or DAPI (1 g/ml).
Total internal reflection microscopy TIRF imaging was performed with a Nikon NSTORM microscope using a 100× (1.46 numerical aperture) oil immersion objective. Fixed neutrophils were imaged under TIRF illumination using a quad cube and the 488 and 647nm lasers. Fluorescence was collected using an Andor iXon EMCCD camera.
TIRF microscopy quantification
To quantify GSDMD localization at the plasma membrane, a region of interest (ROI) outside of the cell, as demarcated by DiD, was captured for every image acquired, and the relative mean fluores cent intensity (MFI) of GSDMD in this region was calculated using ImageJ (ROI>ANALYSE>MEASURE). This value was defined as the background. The MFI of GSDMD was then calculated within the plasma membrane boundaries using DiD. The background MFI was multiplied by 2 and was used as a threshold to determine GSDMD positivity within the confines of the plasma membrane (MFI GSDMD within cell>2× MFI background).
Live imaging of neutrophils
Cells were resuspended in an assay medium supplemented with 500 nM SYTOX Green and 2.5 M DRAQ5 and seeded at a density of 5 × 10 5 cells per well into Slide 8 Well ibiTreat dishes (ibidi). After LDC7559 treatment and NET induction, images were col lected at 2min intervals on a Leica TCS SP8 confocal microscope equipped with a climate chamber at 37°C and with a Leica HC PL APO 20×/0.75 IMM CORR CS2 objective using glycerol immersion. The recording of DRAQ5 (cellpermeable DNA dye) was used to track individual nuclei over time and to determine nuclear area. The recording of SYTOX Green (cellimpermeable dye) was used to determine permeability of cells. Brightfield recording was added for a video representation of the data. Automated algorithms were used to determine the time point of permeabilization and to categorize nuclei into "nonexpanded," "fully expanded" (filling the entire cell), or "NET" (extending beyond the maximal area of a cell). The results were then mapped back to a video represen tation of the data and manually inspected for accuracy before they were used for further analysis. The complete image analysis pipeline consisting of ImageJ and R scripts will be described else where in detail.
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